Gram-Negative BacteriaMarch 25, 20265 min read

Q-Bank Breakdown: Pseudomonas aeruginosa — Why Every Answer Choice Matters

Clinical vignette on Pseudomonas aeruginosa. Explain correct answer, then systematically address each distractor. Tag: Microbiology > Gram-Negative Bacteria.

You’ve seen it in the ICU, you’ve smelled it in the lab, and you’ve missed it at least once in a question stem: Pseudomonas aeruginosa is the USMLE’s favorite “dangerous Gram-negative rod” because it’s clinically distinctive and packed with testable microbiology. Let’s walk through a classic Q-bank vignette, nail the correct answer, then go distractor-by-distractor so you can see why every answer choice matters.


The Clinical Vignette (Q-Bank Style)

A 62-year-old man is admitted to the ICU for septic shock. He was intubated 6 days ago for acute hypoxemic respiratory failure and has been receiving broad-spectrum antibiotics. Today he develops a fever to 39.2°C (102.6°F), leukocytosis, and increased purulent tracheal secretions. Chest X-ray shows a new right lower lobe infiltrate. Sputum culture grows Gram-negative rods that are oxidase-positive, non–lactose fermenting, and produce a blue-green pigment with a fruity (grape-like) odor.

Which virulence factor most directly explains this organism’s ability to inhibit host protein synthesis?

A. Heat-labile enterotoxin that increases cAMP
B. Exotoxin A that ADP-ribosylates EF-2
C. Antiphagocytic capsule
D. IgA protease
E. Lipooligosaccharide (LOS)


The Correct Answer: B. Exotoxin A that ADP-ribosylates EF-2

This is Pseudomonas aeruginosa causing ventilator-associated pneumonia (VAP)—a classic setting (ICU, intubation, broad antibiotics). The question asks specifically about inhibiting host protein synthesis, which points to Exotoxin A.

Why Exotoxin A is High-Yield

  • Mechanism: ADP-ribosylates elongation factor-2 (EF-2) → blocks protein synthesis
  • Same mechanism as: Corynebacterium diphtheriae toxin
  • Board-style phrasing: “Inhibits protein synthesis” / “ADP-ribosylation of EF-2”

Clues in the Stem that Scream Pseudomonas

  • Non–lactose fermenter (MacConkey: pale colonies)
  • Oxidase-positive
  • Blue-green pigment: pyocyanin (and pyoverdin)
  • Fruity/grape-like odor
  • ICU/VAP, burns, CF, neutropenia, hot tubs (folliculitis), contact lens keratitis

Quick “ID Card” Table (Memorize This)

FeaturePseudomonas aeruginosa
Gram stainGram-negative rod
OxygenObligate aerobe
OxidasePositive
Lactose fermentationNon–lactose fermenter
PigmentsPyocyanin (blue-green), pyoverdin
OdorFruity/grape-like
Key virulenceExotoxin A (ADP-ribosylates EF-2)
Classic infectionsVAP, CF pneumonia, burn wound infections, otitis externa (malignant), hot-tub folliculitis, keratitis
Antibiotic notesOften multidrug-resistant; antipseudomonal coverage required

Now the Real Learning: Why Each Distractor is Wrong (and What It Actually Describes)

A. Heat-labile enterotoxin that increases cAMP

Why it’s wrong here: This is a watery diarrhea toxin, not a pneumonia/sepsis ICU pathogen clue. Also, it affects intestinal secretory pathways—not host protein synthesis via EF-2.

What it points to instead (high yield):

  • ETEC heat-labile toxin (LT) → ↑ cAMP (via ADP-ribosylation of Gs)
  • Similar effect to cholera toxin (also ↑ cAMP)
  • Presentation: traveler’s diarrhea, watery stools, no invasion

Test tip:
If you see “watery diarrhea + traveler + no fecal leukocytes” → think ETEC; if you see “rice-water stool” → think Vibrio cholerae.


C. Antiphagocytic capsule

Why it’s wrong here: Pseudomonas does have an alginate biofilm (especially in CF), but the stem asks specifically about inhibiting protein synthesis—that’s Exotoxin A, not a capsule.

What “antiphagocytic capsule” classically screams:

  • Streptococcus pneumoniae (polysaccharide capsule; opsonization with IgG/C3b)
  • Haemophilus influenzae type b (PRP capsule)
  • Neisseria meningitidis (capsule; complement susceptibility if deficient)
  • Klebsiella pneumoniae (thick, mucoid capsule; currant jelly sputum)

Pseudomonas nuance worth knowing:

  • In cystic fibrosis, Pseudomonas often becomes mucoid due to alginatebiofilm, chronic colonization, antibiotic tolerance.

D. IgA protease

Why it’s wrong here: IgA protease helps organisms colonize mucosal surfaces, but it’s not the classic “protein synthesis inhibitor” and doesn’t match the pigment/odor/oxidase clues.

IgA protease organisms (memorize the list):

  • S. pneumoniae
  • H. influenzae
  • N. meningitidis
  • N. gonorrhoeae

How it shows up in stems:

  • Recurrent mucosal infections, otitis media/sinusitis (S. pneumo, H. flu)
  • STI with purulent discharge (N. gonorrhoeae)
  • Meningitis with petechiae (N. meningitidis)

E. Lipooligosaccharide (LOS)

Why it’s wrong here: Pseudomonas has LPS, not LOS. LOS is a shortened endotoxin structure typical of Neisseria (and some others like H. influenzae). Also, LOS is an endotoxin inflammatory trigger, not a direct inhibitor of protein synthesis.

What LOS points to:

  • Neisseria meningitidis: LOS contributes to endotoxemia, DIC, shock
  • Neisseria gonorrhoeae: local inflammation

Board correlation:

  • LOS/LPS → activates macrophages → cytokines (TNF-α, IL-1), complement → fever, shock
  • But “inhibits host protein synthesis” → think EF-2 toxins (Pseudomonas, diphtheria)

High-Yield Pseudomonas Facts That Commonly Get Tested

1) Virulence & Pathogenesis

  • Exotoxin A: ADP-ribosylates EF-2 → inhibits protein synthesis
  • Biofilm (alginate): especially in CF; increases antibiotic tolerance and chronic infection
  • Elastase: tissue destruction; can contribute to hemorrhagic phenomena in severe infections
  • Endotoxin (LPS): septic shock physiology (fever, hypotension)

2) Classic Clinical Associations

  • Ventilator-associated pneumonia
  • CF pneumonia (chronic colonizer; mucoid phenotype)
  • Burn wound infections (think green-blue discharge)
  • Malignant otitis externa (older adults, diabetes; severe ear pain)
  • Hot-tub folliculitis
  • Keratitis (contact lens users)

3) Lab ID “Buzzwords”

  • Oxidase-positive
  • Non–lactose fermenter
  • Blue-green pigment (pyocyanin)
  • Fruity/grape odor
  • Aerobic, thrives in moist environments (sinks, respiratory equipment)

Treatment Logic (USMLE-Level)

If they’re asking empiric coverage for a sick ICU patient with suspected Pseudomonas, you need antipseudomonal therapy, often two agents in severe illness until susceptibilities return.

Antipseudomonal options to recognize:

  • Piperacillin-tazobactam
  • Cefepime or ceftazidime
  • Meropenem or imipenem (not ertapenem)
  • Aztreonam (useful in some beta-lactam allergies)
  • Add-on options: aminoglycosides (e.g., tobramycin, amikacin), fluoroquinolones (ciprofloxacin, levofloxacin)

Step-style pearl:
If they mention CF pulmonary exacerbation, inhaled tobramycin is a classic board favorite (plus systemic therapy depending on severity).


Takeaway: A One-Liner You Can Use Under Time Pressure

Pseudomonas aeruginosa = ICU/burns/CF + oxidase+ non–lactose fermenting GNR + blue-green pigment + grape odorExotoxin A ADP-ribosylates EF-2 (like diphtheria) → inhibits protein synthesis.